These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1892622)
1. Oral vaccine therapy for pneumococcal otitis media in an animal model. Yoshimura H; Watanabe N; Bundo J; Shinoda M; Mogi G Arch Otolaryngol Head Neck Surg; 1991 Aug; 117(8):889-94. PubMed ID: 1892622 [TBL] [Abstract][Full Text] [Related]
2. Induction of antigen-specific IgA-forming cells in the middle ear mucosa. Watanabe N; Yoshimura H; Mogi G Arch Otolaryngol Head Neck Surg; 1988 Jul; 114(7):758-62. PubMed ID: 3382529 [TBL] [Abstract][Full Text] [Related]
3. Otitis-prone Children Have Immunologic Deficiencies in Naturally Acquired Nasopharyngeal Mucosal Antibody Response after Streptococcus pneumoniae Colonization. Xu Q; Casey JR; Newman E; Pichichero ME Pediatr Infect Dis J; 2016 Jan; 35(1):54-60. PubMed ID: 26448450 [TBL] [Abstract][Full Text] [Related]
4. Possibilities of preventing otitis media by vaccination. Mäkelä PH; Karma P; Sipilä M; Pukander J; Leinonen M Scand J Infect Dis Suppl; 1983; 39():34-8. PubMed ID: 6359378 [TBL] [Abstract][Full Text] [Related]
5. Role of antibodies and IL17-mediated immunity in protection against pneumococcal otitis media. Habets MN; van Selm S; van Opzeeland FJ; Simonetti E; Hermans PWM; de Jonge MI; Diavatopoulos DA Vaccine; 2016 Nov; 34(48):5968-5974. PubMed ID: 27771185 [TBL] [Abstract][Full Text] [Related]
6. Correlation of higher antibody levels to pneumococcal proteins with protection from pneumococcal acute otitis media but not protection from nasopharyngeal colonization in young children. Xu Q; Casey JR; Almudevar A; Pichichero ME Clin Microbiol Infect; 2017 Jul; 23(7):487.e1-487.e6. PubMed ID: 28143785 [TBL] [Abstract][Full Text] [Related]
7. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae. Xu JH; Dai WJ; Chen B; Fan XY Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478 [TBL] [Abstract][Full Text] [Related]
8. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children. Simell B; Kilpi TM; Käyhty H J Infect Dis; 2002 Oct; 186(8):1106-14. PubMed ID: 12355361 [TBL] [Abstract][Full Text] [Related]
9. Prevention of otitis media in children by pneumococcal vaccination. Karma P; Pukander J; Sipilä M; Timonen M; Pöntynen S; Herva E; Grönroos P; Mäkelä H Am J Otolaryngol; 1985; 6(3):173-84. PubMed ID: 3893185 [TBL] [Abstract][Full Text] [Related]
10. Animal models for studying pneumococcal otitis media and pneumococcal vaccine efficacy. Giebink GS; Berzins IK; Quie PG Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):339-43. PubMed ID: 6778342 [TBL] [Abstract][Full Text] [Related]
11. Effect of combined pneumococcal conjugate and polysaccharide vaccination on recurrent otitis media with effusion. van Heerbeek N; Straetemans M; Wiertsema SP; Ingels KJ; Rijkers GT; Schilder AG; Sanders EA; Zielhuis GA Pediatrics; 2006 Mar; 117(3):603-8. PubMed ID: 16510637 [TBL] [Abstract][Full Text] [Related]
12. Active immunisation and resistance to experimental acute pneumococcal otitis media. Svinhufvud M; Hermansson A; Prellner K Int J Pediatr Otorhinolaryngol; 1993 Jan; 25(1-3):91-103. PubMed ID: 8436484 [TBL] [Abstract][Full Text] [Related]
13. Higher levels of mucosal antibody to pneumococcal vaccine candidate proteins are associated with reduced acute otitis media caused by Streptococcus pneumoniae in young children. Xu Q; Casey JR; Pichichero ME Mucosal Immunol; 2015 Sep; 8(5):1110-7. PubMed ID: 25648056 [TBL] [Abstract][Full Text] [Related]
14. Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies. Nieminen T; Käyhty H; Leroy O; Eskola J Pediatr Infect Dis J; 1999 Sep; 18(9):764-72. PubMed ID: 10493335 [TBL] [Abstract][Full Text] [Related]
15. Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model. Xu Q; Pryharski K; Pichichero ME Vaccine; 2017 Jan; 35(2):337-344. PubMed ID: 27919628 [TBL] [Abstract][Full Text] [Related]
16. Polysaccharide-based pneumococcal vaccines in the prevention of acute otitis media. Eskola J Vaccine; 2000 Dec; 19 Suppl 1():S78-82. PubMed ID: 11163468 [TBL] [Abstract][Full Text] [Related]
17. Serum IgA and IgG functional antibodies and their subclasses to Streptococcus pneumoniae capsular antigen found in two aged-matched cohorts of children with and without otitis media with effusion. Drake-Lee AB; Hughes RG; Dunn C Clin Otolaryngol Allied Sci; 2003 Aug; 28(4):335-40. PubMed ID: 12871248 [TBL] [Abstract][Full Text] [Related]
18. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media. Sabirov A; Metzger DW Vaccine; 2006 Jul; 24(27-28):5584-92. PubMed ID: 16730398 [TBL] [Abstract][Full Text] [Related]
19. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta. Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217 [TBL] [Abstract][Full Text] [Related]
20. Free radical production by antibiotic-killed bacteria in the guinea pig middle ear. Takoudes TG; Haddad J Laryngoscope; 2001 Feb; 111(2):283-9. PubMed ID: 11210876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]